IRIS - Res&Arch Institutional Research Information System - Research & Archive
Anagrafe della Ricerca dell'Università degli Studi di Perugia.
EnglishAtopic dermatitis (AD) is a common inflammatory skin disease with high prevalence both in children (15-30%) and adults (2-10%); limited data are available for the elderly. Elderly patients are challenging showing frequent multiple comorbidities, associated polypharmacy, and common previously treatments failure. We performed a retrospective observational study on elderly (≥ 65 year-old) patients treated with dupilumab, monoclonal antibody to the shared alpha subunit of the IL4 and IL-13 receptor approved for the treatment of moderate-to-severe AD in adults.
Scheda prodotto non validato
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
| Titolo: | Efficacy and safety of dupilumab in atopic dermatitis of the elderly: A retrospective study |
| Autori: | |
| Data di pubblicazione: | Being printed |
| Rivista: | |
| Abstract: | Atopic dermatitis (AD) is a common inflammatory skin disease with high prevalence both in children (15-30%) and adults (2-10%); limited data are available for the elderly. Elderly patients are challenging showing frequent multiple comorbidities, associated polypharmacy, and common previously treatments failure. We performed a retrospective observational study on elderly (≥ 65 year-old) patients treated with dupilumab, monoclonal antibody to the shared alpha subunit of the IL4 and IL-13 receptor approved for the treatment of moderate-to-severe AD in adults. |
| Handle: | http://hdl.handle.net/11391/1470309 |
| Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Copyright © 2020